PlainPharmaWatch

CMS Open Payments · Tool

Mesh Suture Inc vs Ortho-Clinical Diagnostics, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Ortho-Clinical Diagnostics, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,099, versus 1,063 for the other company. Its single largest recorded recipient represents 28.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Mesh Suture Inc
HHI 1,063 · top recipient 27.0%
Ranked #1,005 of 1,838 companies by HHI
Ortho-Clinical Diagnostics, Inc.
HHI 2,099 · top recipient 28.8%
Ranked #733 of 1,838 companies by HHI

Payment Overview

Company A

Mesh Suture Inc

Total Payments
$10.8M
% of Industry
0.1%
Transactions
91
Avg per Transaction
$119.2K
Recipients
86
Avg per Recipient
$126.1K
Payment Types
2
Top Payment Type
Food and Beverage
Total Payments
$10.7M
% of Industry
0.1%
Transactions
666
Avg per Transaction
$16.0K
Recipients
232
Avg per Recipient
$46.1K
Payment Types
6
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Mesh Suture Inc vs Ortho-Clinical Diagnostics, Inc. - total reported payments in CMS Open Payments PY2024

Mesh Suture Inc$10.8MOrtho-Clinical Diagnostics,…$10.7M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Mesh Suture Inc

Food and Beverage $6.4K

57.0%

Consulting Fee $4.8K

43.0%

Ortho-Clinical Diagnostics, Inc.

Consulting Fee $679.4K

59.6%

Compensation for Services Other Than Consulting $340.9K

29.9%

Royalty or License $50.2K

4.4%

Debt Forgiveness $35.7K

3.1%

Travel and Lodging $23.5K

2.1%

Food and Beverage $9.5K

0.8%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Mesh Suture Inc

  1. 1

    ERIC PAULI

    $3,010.27 · 5 txns

  2. 2

    VINAYAK ROHAN

    $1,800.00 · 2 txns

  3. 3

    LUIS GARCIA

    $210.64 · 2 txns

  4. 4

    CHARLES JEHLE

    $194.01 · 1 txns

  5. 5

    MATTHEW MILLER

    $194.01 · 1 txns

Ortho-Clinical Diagnostics, Inc.

  1. 1

    KENNETH WIDDER

    $328,512.92 · 3 txns

  2. 2

    MARY POLAN

    $314,827.75 · 3 txns

  3. 3

    Uhs Hospitals

    $243,190.00 · 9 txns

  4. 4

    Strong Memorial Hospital

    $47,167.60 · 3 txns

  5. 5

    Paul Olivo

    $34,655.91 · 13 txns

Summary Comparison

Metric Mesh Suture Inc Ortho-Clinical Diagnostics, Inc.
Total Payments $10.8M $10.7M
% of Industry Total 0.1% 0.1%
Transaction Count 91 666
Avg per Transaction $119.2K $16.0K
Recipient Count 86 232
Avg per Recipient $126.1K $46.1K
Payment Type Count 2 6
Top Payment Type Food and Beverage Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.